Czech National Bank Purchases 2,577 Shares of Cardinal Health, Inc. $CAH

Czech National Bank boosted its stake in Cardinal Health, Inc. (NYSE:CAH) by 4.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 66,664 shares of the company’s stock after acquiring an additional 2,577 shares during the period. Czech National Bank’s holdings in Cardinal Health were worth $15,837,000 as of its most recent filing with the SEC.

Several other institutional investors have also added to or reduced their stakes in CAH. University of Texas Texas AM Investment Management Co. purchased a new stake in Cardinal Health in the 4th quarter worth approximately $26,000. Bank of Jackson Hole Trust bought a new position in shares of Cardinal Health during the 4th quarter valued at about $27,000. Jones Financial Companies Lllp boosted its stake in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares in the last quarter. Palladiem LLC purchased a new position in shares of Cardinal Health in the fourth quarter worth about $28,000. Finally, Indiana Trust & Investment Management Co purchased a new position in Cardinal Health in the 1st quarter worth approximately $29,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. TD Cowen increased their target price on Cardinal Health from $255.00 to $275.00 and gave the stock a “buy” rating in a research report on Thursday, July 9th. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 4th. Wells Fargo & Company lowered their price objective on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Bank of America lifted their price objective on shares of Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a research note on Thursday, July 2nd. Finally, JPMorgan Chase & Co. reduced their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research note on Monday, May 4th. Fifteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $251.73.

Cardinal Health Trading Down 0.5%

Shares of NYSE CAH opened at $236.57 on Friday. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $244.87. The company has a 50-day moving average of $226.64 and a 200 day moving average of $216.23. The stock has a market cap of $55.41 billion, a PE ratio of 36.17, a P/E/G ratio of 1.16 and a beta of 0.49.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.